AQP4 and myelitis: Nonetheless, this heterogeneity in clinical and MRI activity, combined with the inclusion of NMOSD AQP4 + patients presenting with either optic neuritis or myelitis, may have introduced variability that could affect CSF cytokine profiles and their relationship with neurological disability.